Skip to main content
. 2018 Aug 23;13(8):e0202165. doi: 10.1371/journal.pone.0202165

Fig 3. Femoral BMD in TR mice and effect of minodronate.

Fig 3

(A) Total femoral BMD in each group at age of 9 weeks. Values shown are mean ± SD. (n = 6 for each group; ***p< 0.001, significantly different from the TR/VEH group as reference (Dunnett’s test).) (B) Effect of TR and minodronate treatment on markers of bone turnover in each group. Values shown are mean ± SD. (n = 6 for CON/VEH, CON/MIN and TR/VEH, and n = 9 for TR/MIN; *p< 0.05 and **p< 0.01, significantly different from the TR/VEH group as reference (Dunnett’s test). N.S. not significant).